Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Neuroectodermal Tumors, Primitive × Mannitol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Oligodendroglioma 1 Neuroectodermal Tumors, Primitive 1 Neoplasms, Germ Cell and Embryonal 1 Medulloblastoma 1 Glioma 1 Breast Neoplasms 1 Astrocytoma 1

Interventions

Radiotherapy 2 sodium thiosulfate 1 poly ICLC 1 plerixafor 1 adavosertib 1 Vaccines 1 Temozolomide 1 Radiation 1 Melphalan 1 Mannitol 1 Irinotecan 1 Decitabine 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00983398 2021-10-26

Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CNS Embryonal or Germ Cell Tumors

OHSU Knight Cancer Institute

Phase 1/2 Unknown

Medulloblastoma, Neoplasms, Germ Cell and Embryonal, Neuroectodermal Tumors, Primitive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡